id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0012-0010,FDA,FDA-1975-N-0012,Letter from FDA/CDER to Hy-Gene Biomedical Corporation,Other,Letter(s),2005-02-23T05:00:00Z,2005,2,,,2017-10-30T14:43:40Z,,0,0,09000064805c1cd3